They reported that LIPT1 (Lipoyltransferase 1), PDHA1 (pyruvate dehydrogenase E1 subunit alpha 1), GLS (Glutaminase), and CDKN2A (Cyclin-Dependent Kinase Inhibitor 2A) had significantly higher expression levels in CRC tissues than in normal tissues, while FDX1, DLD (dihydrolipoamide dehydrogenase), and MTF1 (Metal Regulatory Transcription Factor 1) had significantly lower expression levels in CRC tissues than in normal tissues [77]. The gene discussed is GLS; the disease is colorectal carcinoma.